Treatment-related acute myeloid leukemia characterized by t(11;20)(p15;q11) and del(9)(q22).
Haimi
Motti
M
Motti
Haimi
H
Avivi
Irit
I
Irit
Avivi
A
Moustafa
Nivin
N
Nivin
Moustafa
M
Aboleil
Olfat
O
Olfat
Aboleil
A
Gershoni-Baruch
Ruth
R
Ruth
Gershoni-Baruch
GB
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002872:Chromosome Deletion; D002880:Chromosomes, Human, Pair 11 / Q000648:ultrastructure; D002890:Chromosomes, Human, Pair 20 / Q000648:ultrastructure; D002899:Chromosomes, Human, Pair 9 / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced* / Q000175:diagnosis* / Q000235:genetics; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis* / Q000235:genetics; D012074:Remission Induction; D014178:Translocation, Genetic
D000970:Antineoplastic Agents